×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Immunovaccine to Present at 6th Annual Biotech Showcase Conference
Yahoo Life UK
Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that the Company will present at the 6th Annual Biotech Showcase...
3 days ago
IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
Business Wire
IMV Inc. (the “Company” or “IMV”) announces today that it has accepted an offer (the “Offer”) from IMV's largest secured creditors (the...
8 months ago
Court grants creditor protection to N.S. company developing cancer treatments
CBC
IMV — known as Immunovaccine Technologies — disclosed Monday the Nova Scotia Supreme Court has granted an interim order giving it protection...
12 months ago
Immunovaccine's targeted ovarian cancer therapy wins orphan drug status in EU
Drug Delivery Business
Immunovaccine's targeted ovarian cancer therapy wins orphan drug status in EU ... Immunovaccine Inc. said today that the European Medicines Agency...
89 months ago
BioVaxys Acquires Full Portfolio of Former IMV
PharmTech
BioVaxys has acquired the full portfolio of discovery, preclinical, and clinical development-stage assets of the former IMV.
2 months ago
GSK and Immunovaccine: delivery techs promise to deliver Ebola vaccine
biopharma-reporter.com
A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a...
116 months ago
ImmunoVaccine Technologies to Acquire Immunotope
Technology Networks
The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen...
196 months ago
Korean biotechs snatch U.S. stem cell manufacturing facility
Fierce Pharma
A pair of Korean biotechs have teamed up to buy stem cell manufacturing facilities and other assets of a failed U.S. biotech to establish a...
62 months ago
SPiReL - Sunnybrook Research Institute
Sunnybrook Hospital
The SPiReL study is a clinical trial that will examine the effects of using three immunotherapy treatments in combination, in patients with DLBCL that has...
65 months ago
IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia
GlobeNewswire
DARTMOUTH, Nova Scotia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation,...
67 months ago